Anove-logoAnove-logoExplAIn
KaartenAI-koplopers
Terug naar directory

M&M (Minority & Majority classifier)

door Prinses Máxima Centrum

AI Application
Laag vertrouwen

M&M (Minority & Majority classifier) is a machine-learning tool that suggests the tumour type and subtype of a childhood cancer from RNA-sequencing data of the tumour. It is used in a paediatric oncology diagnostic laboratory, where pathologists and haematologists make the diagnosis. Its developers at the Prinses Máxima Centrum say it compares each new patient's gene-expression profile with all profiles measured before, combining two ensembles of weighted random-forest models, one aimed at rare and one at more frequent tumour (sub)types. It covers 52 tumour types and 96 subtypes; the developers report about 99% precision for confident tumour-type calls on internal test data; calls below a probability threshold are flagged as low confidence. The Máxima describes it as a tool the pathologist or haematologist uses to confirm their own diagnosis or, when in doubt, to reach a precise one; the paper says its output should always be weighed against other information. The R package is on GitHub under GPL-3.0 and the trained models on Zenodo; hosting is not stated.

Bezoek website

Transparantiescore

Gewogen over vier pijlers · bijgewerkt October 20, 2026

Totaalscore
10% gewogen
ABCDF
Model
—
Nog niet beoordeeld
Infrastructuur
—
Nog niet beoordeeld

Functionaliteiten

Paediatric Tumour Type Classification
Tumour Subtype Classification
Rna Expression Profile Comparison
Diagnosis Confirmation Support
Confidence Scoring

Leveranciersinformatie

Volledige informatie over de leverancier/provider van deze AI-applicatie

Prinses Máxima CentrumBekijk alle producten →
Prinses Máxima Centrum voor Kinderoncologie B.V.(Handelsnaam: Prinses Máxima Centrum)
Contactinformatie
www.prinsesmaximacentrum.nl
Geregistreerd adres
Heidelberglaan 25, Utrecht, Utrecht, 3584 CS, NL

Leveranciersinformatie volgens de EU AI Act

Verificatiestatus:
Unverified
Prinses Máxima Centrum voor Kinderoncologie B.V.(Handelsnaam: Prinses Máxima Centrum)
Heidelberglaan 25, Utrecht, Utrecht, 3584 CS, NL
For M&M, the Máxima's developers state in their paper that 'M&M's classification should always be assessed in light of other available information to come to a final diagnosis', that 'additional verification showing the prospective performance in an extended clinical setting is needed for standard-of-care use', that subtype calls perform worse than tumour-type calls, that (very) rare tumour (sub)types with fewer than three reference samples are excluded, and that replacing the DKFZ CNS methylation classifier with M&M 'would currently not be recommended'. Calls below a probability threshold (about 0.82 for tumour type, 0.72 for subtype) are reported as low confidence. The GitHub README says input transcript names must be HGNC symbols (Wallis et al., eBioMedicine 2025, https://europepmc.org/article/PMC/PMC11784659; https://github.com/princessmaximacenter/MnM; both read 2026-10-20).
Naleving & risico

Krijg inzicht in risico's door beoordelingen uit te voeren op deze AI-applicatie.

Werk je bij Prinses Máxima Centrum? Claim deze vermelding om de gegevens te corrigeren of aan te vullen.

Toegevoegd: October 20, 2026
Bijgewerkt: October 20, 2026

Klaar om AI-applicaties te beheren?

Volg, beoordeel en beheer je AI-applicaties met Anove.

Anove-logoAnove-logoAnove International B.V.

We helpen organisaties AI-applicaties op een verantwoorde manier te ontdekken en beheren. Uw betrouwbare bron voor AI-governance en compliance.

Snelle links

  • Directory bekijken
  • FAQ
  • AI-kaarten per sector
  • Inloggen

Bronnen

  • Documentatie
  • Status
  • Anove.ai

Voorwaarden

  • Privacybeleid
  • Algemene voorwaarden
  • Responsible disclosure
  • AI-juridische kennisgeving
  • Beveiligingsbeleid

© 2026 Anove International B.V. Alle rechten voorbehouden.